BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 18566376)

  • 1. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis.
    Jurado JO; Alvarez IB; Pasquinelli V; Martínez GJ; Quiroga MF; Abbate E; Musella RM; Chuluyan HE; García VE
    J Immunol; 2008 Jul; 181(1):116-25. PubMed ID: 18566376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role played by the programmed death-1-programmed death ligand pathway during innate immunity against Mycobacterium tuberculosis.
    Alvarez IB; Pasquinelli V; Jurado JO; Abbate E; Musella RM; de la Barrera SS; García VE
    J Infect Dis; 2010 Aug; 202(4):524-32. PubMed ID: 20617899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands.
    Kinter AL; Godbout EJ; McNally JP; Sereti I; Roby GA; O'Shea MA; Fauci AS
    J Immunol; 2008 Nov; 181(10):6738-46. PubMed ID: 18981091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-1 modulating Mycobacterium tuberculosis-specific polarized effector memory T cells response in tuberculosis pleurisy.
    Li J; Jin C; Wu C; Huang J
    J Leukoc Biol; 2019 Sep; 106(3):733-747. PubMed ID: 30861206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BATF Potentially Mediates Negative Regulation of PD-1/PD-Ls Pathway on T Cell Functions in
    Liu Q; Ou Q; Shen L; Qiu C; Zhang B; Zhang W; Shao L; Gao Y; Chen ZW
    Front Immunol; 2019; 10():2430. PubMed ID: 31681314
    [No Abstract]   [Full Text] [Related]  

  • 6. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.
    Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ
    J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-1/PD-Ls pathways between CD4(+) T cells and pleural mesothelial cells in human tuberculous pleurisy.
    Yin W; Tong ZH; Cui A; Zhang JC; Ye ZJ; Yuan ML; Zhou Q; Shi HZ
    Tuberculosis (Edinb); 2014 Mar; 94(2):131-9. PubMed ID: 24406080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B Cells and Programmed Death-Ligand 2 Signaling Are Required for Maximal Interferon-γ Recall Response by Splenic CD4⁺ Memory T Cells of Mice Vaccinated with Mycobacterium tuberculosis Ag85B.
    Riccomi A; Palma C
    PLoS One; 2015; 10(9):e0137783. PubMed ID: 26379242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of signaling lymphocytic activation molecule-associated protein interrupts IFN-gamma production in human tuberculosis.
    Pasquinelli V; Quiroga MF; Martínez GJ; Zorrilla LC; Musella RM; Bracco MM; Belmonte L; Malbrán A; Fainboim L; Sieling PA; García VE
    J Immunol; 2004 Jan; 172(2):1177-85. PubMed ID: 14707094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed death-1
    Singh A; Mohan A; Dey AB; Mitra DK
    Clin Exp Immunol; 2017 Feb; 187(2):269-283. PubMed ID: 27665733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses.
    Bennett F; Luxenberg D; Ling V; Wang IM; Marquette K; Lowe D; Khan N; Veldman G; Jacobs KA; Valge-Archer VE; Collins M; Carreno BM
    J Immunol; 2003 Jan; 170(2):711-8. PubMed ID: 12517932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibiting the programmed death 1 pathway rescues Mycobacterium tuberculosis-specific interferon γ-producing T cells from apoptosis in patients with pulmonary tuberculosis.
    Singh A; Mohan A; Dey AB; Mitra DK
    J Infect Dis; 2013 Aug; 208(4):603-15. PubMed ID: 23661793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-L2:PD-1 involvement in T cell proliferation, cytokine production, and integrin-mediated adhesion.
    Saunders PA; Hendrycks VR; Lidinsky WA; Woods ML
    Eur J Immunol; 2005 Dec; 35(12):3561-9. PubMed ID: 16278812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable increased expression of program death-1 and program death-1 ligands on peripheral mononuclear cells is not impaired in patients with systemic lupus erythematosus.
    Liu MF; Weng CT; Weng MY
    J Biomed Biotechnol; 2009; 2009():406136. PubMed ID: 19759858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phagocytosis, a potential mechanism for myeloid-derived suppressor cell regulation of CD8+ T cell function mediated through programmed cell death-1 and programmed cell death-1 ligand interaction.
    Kim YJ; Park SJ; Broxmeyer HE
    J Immunol; 2011 Sep; 187(5):2291-301. PubMed ID: 21795591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of programmed death 1 ligands by murine T cells and APC.
    Yamazaki T; Akiba H; Iwai H; Matsuda H; Aoki M; Tanno Y; Shin T; Tsuchiya H; Pardoll DM; Okumura K; Azuma M; Yagita H
    J Immunol; 2002 Nov; 169(10):5538-45. PubMed ID: 12421930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An optimized protocol for the in vitro generation and functional analysis of human PD1/PD-L1 signal.
    Khedri M; Abnous K; Rafatpanah H; Ramezani M
    J Recept Signal Transduct Res; 2018 Feb; 38(1):31-36. PubMed ID: 29252078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFN-γ decreased the suppressive function of CD33
    Zhan X; Hu S; Wu Y; Li M; Liu T; Ming S; Wu M; Liu M; Huang X
    Mol Immunol; 2018 Feb; 94():107-120. PubMed ID: 29291452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.
    Fife BT; Bluestone JA
    Immunol Rev; 2008 Aug; 224():166-82. PubMed ID: 18759926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.